Belkyra, known as Kybella in the United States, offers a non-surgical solution for reducing submental fat, commonly referred to as a double chin. This injectable treatment utilises deoxycholic acid, a naturally occurring molecule in the body that aids in the breakdown and absorption of dietary fat. By targeting and destroying fat cells, Belkyra provides a noticeable reduction in fullness under the chin, improving the overall facial profile.
How Belkyra Works
The primary component of Belkyra is deoxycholic acid, which disrupts fat cell membranes, leading to cell destruction. Once destroyed, these cells are naturally metabolised and eliminated by the body’s lymphatic system. The treatment involves a series of small injections administered in a grid pattern under the chin, tailored to the individual’s aesthetic goals. Typically, multiple sessions are required to achieve optimal results, with each session spaced several weeks apart.
Advantages Over Surgical Options
One of the main benefits of Belkyra is that it offers a non-invasive alternative to surgical fat reduction methods, such as liposuction. This means no incisions, no sutures, and consequently, no scarring. Recovery time is significantly reduced, with most patients experiencing minimal downtime. Side effects are usually limited to temporary swelling, bruising, or numbness in the treatment area, which resolve on their own.
Long-lasting Results
Once the targeted fat cells are destroyed, they can no longer store or accumulate fat, leading to long-lasting results. However, maintaining a stable weight is essential to preserve the outcome, as significant weight fluctuations can affect the appearance. The treatment is particularly beneficial for those who struggle with diet and exercise-resistant fat in the submental area, offering a tailored solution to enhance facial contours.
Belkyra provides a precise and targeted approach to fat reduction in the submental area, making it an ideal choice for individuals seeking a non-surgical option. The treatment is customisable, allowing practitioners to adjust the number of injections and sessions based on individual needs and desired outcomes.
The non-surgical nature of Belkyra means that patients can avoid the risks associated with surgery, such as infection or anaesthesia complications. This makes it an appealing option for those looking for a safer, less invasive method to improve their appearance.
Furthermore, Belkyra’s ability to achieve long-lasting results with minimal downtime is a significant advantage for patients with busy lifestyles. The convenience of the procedure, combined with its efficacy, contributes to its growing popularity as a preferred method for reducing unwanted fat under the chin.
